ID

2383

Beschreibung

F1 Radiation Therapy Oncology Group Phase III Randomized Study of Intermediate Risk Prostate Cancer Follow-up Form Late RT Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AA8904F6-5E04-5881-E034-0003BA12F5E7

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AA8904F6-5E04-5881-E034-0003BA12F5E7

Stichworte

Versionen (2)
  1. 19.09.12 19.09.12 -
  2. 23.03.15 23.03.15 - Martin Dugas
Hochgeladen am

19. September 2012

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0 Legacy
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

NCT00063882 Follow-Up - F1 Radiation Therapy Oncology Group Phase III Randomized Study of Intermediate Risk Prostate Cancer Follow-up Form Late RT - 2057680v3.0

Englisch

INSTRUCTIONS: Submit this form at the appropriate followup interval. Use -1 for unknown or not applicable unless otherwise specified in codetable. All dates to be reported mm-dd-yyyy unless otherwise indicated.

1 Formulare  
Unnamed1
Beschreibung

Unnamed1

AMENDED DATA
Beschreibung

AmendedDataInd

Datentyp

text

Alias
NCI Thesaurus ObjectClass
C25474
UMLS 2011AA ObjectClass
C1511726
NCI Thesaurus Property
C25416
UMLS 2011AA Property
C1691222
Unnamed2
Beschreibung

Unnamed2

RTOG Study
Beschreibung

RTOGStudy

Datentyp

text

Case #
Beschreibung

Case#

Datentyp

text

Institution Name
Beschreibung

InstitutionName

Datentyp

text

Institution No.
Beschreibung

NCIInstitutionNumber

Datentyp

text

Patient Name, Last
Beschreibung

PatientName,Last

Datentyp

text

Patient Name, First
Beschreibung

PatientName,First

Datentyp

text

Unnamed3
Beschreibung

Unnamed3

Unnamed4
Beschreibung

Unnamed4

PATIENT'S VITAL STATUS
Beschreibung

Patient'sVitalStatus

Datentyp

text

DATE OF LAST CONTACT OR DEATH
Beschreibung

DeathDate/LastContactDate

Datentyp

date

CAUSE OF DEATH
Beschreibung

DeathReason

Datentyp

text

Due to other cause, specify (cause of death)
Beschreibung

DeathCauseText

Datentyp

text

Alias
NCI Thesaurus Property
C25638
UMLS 2011AA Property
C0392360
NCI Thesaurus ObjectClass
C28554
UMLS 2011AA ObjectClass
C0011065
NCI Thesaurus Property
C25251
UMLS 2011AA Property
C0205225
HAS THE PATIENT HAD A DOCUMENTED CLINICAL ASSESSMENT FOR PROSTATE CANCER SINCE SUBMISSION OF THE PREVIOUS FOLLOWUP FORM?
Beschreibung

CancerFollow-upStatusInd

Datentyp

text

DATE OF LAST CLINICAL ASSESSMENT
Beschreibung

CancerFollow-upStatusDate

Datentyp

date

Alias
NCI Thesaurus ObjectClass
C2991
UMLS 2011AA ObjectClass
C0012634
NCI Thesaurus Property
C25365
UMLS 2011AA Property
C0678257
PERFORMANCE STATUS (ZUBROD)
Beschreibung

PerformanceStatus

Datentyp

text

Follow-up PSA Value(s)
Beschreibung

PSAValue

Datentyp

double

Date of PSA Assessment(s)
Beschreibung

PSADate

Datentyp

date

HAS THE PATIENT HAD A PROSTATE BIOPSY SINCE SUBMISSION OF THE LAST FOLLOWUP FORM?
Beschreibung

HASTHEPATIENTHADAPROSTATEBIOPSYSINCESUBMISSIONOFTHELASTFOLLOWUPFORM?

Datentyp

text

Alias
NCI Thesaurus ValueDomain
C25704
UMLS 2011AA ValueDomain
C1527021
NCI Thesaurus ValueDomain
C25180
UMLS 2011AA ValueDomain
C1522602
Biopsy Date
Beschreibung

BiopsyDate

Datentyp

date

HAS THE PATIENT DEVELOPED A FIRST PROGRESSION THAT HAS NOT BEEN PREVIOUSLY REPORTED?
Beschreibung

ProgressionInd

Datentyp

text

HAS THE PATIENT BEEN DIAGNOSED WITH BIOCHEMICAL RECURRENCE SINCE SUBMISSION OF LAST FOLLOW-UP FORM? (See Protocol Section 11)
Beschreibung

ProgressionInd,Biochemical

Datentyp

text

Date of first biochemical progression
Beschreibung

ProgressionDate,FirstBiochemical

Datentyp

date

PSA Value at progression
Beschreibung

ProgressionPSAValue

Datentyp

double

HAS THE PATIENT BEEN DIAGNOSED WITH FIRST LOCAL-REGIONAL RECURRENCE SINCE SUBMISSION OF LAST FOLLOW-UP FORM? (See Protocol Section 11)
Beschreibung

ProgressionInd,FirstLocal-Regional

Datentyp

text

Date of First Local-Regional Progression
Beschreibung

ProgressionDate,FirstLocal-Regional

Datentyp

date

Site(s) of Local/Regional Progression
Beschreibung

ProgressionSite

Datentyp

text

WHAT WAS THE METHOD USED TO DETERMINE distant PROGRESSION
Beschreibung

AssessmentType

Datentyp

text

WHAT WAS THE METHOD USED TO DETERMINE distant PROGRESSION
Beschreibung

AssessmentType

Datentyp

text

Other, specify (method used to determine distant progression)
Beschreibung

AssessmentType,Specify

Datentyp

text

Other, specify (method used to determine distant progression)
Beschreibung

AssessmentType,Specify

Datentyp

text

HAS THE PATIENT BEEN DIAGNOSED WITH FIRST DISTANT RECURRENCE SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM?
Beschreibung

ProgressionInd,FirstDistant

Datentyp

text

Date of First Distant Progression
Beschreibung

ProgressionDate,FirstDistant

Datentyp

date

Site(s) of First Distant Progression
Beschreibung

ProgressionSite,FirstDistant

Datentyp

text

Unnamed5
Beschreibung

Unnamed5

AMENDED DATA
Beschreibung

AmendedDataInd

Datentyp

text

Alias
NCI Thesaurus ObjectClass
C25474
UMLS 2011AA ObjectClass
C1511726
NCI Thesaurus Property
C25416
UMLS 2011AA Property
C1691222
DATE FROM (Q2)
Beschreibung

IntervalReportFromDate

Datentyp

date

Unnamed6
Beschreibung

Unnamed6

RTOG Study
Beschreibung

RTOGStudy

Datentyp

text

Case #
Beschreibung

Case#

Datentyp

text

Institution Name
Beschreibung

InstitutionName

Datentyp

text

Institution No.
Beschreibung

NCIInstitutionNumber

Datentyp

text

Patient Name, Last
Beschreibung

PatientName,Last

Datentyp

text

Patient Name, First
Beschreibung

PatientName,First

Datentyp

text

Unnamed7
Beschreibung

Unnamed7

DID THE PATIENT RECEIVE ANY NON-PROTOCOL PROSTATE CANCER THERAPY SINCE THE LAST FOLLOW-UP (If yes, enter therapy type and date for each therapy delivered during the follow-up period.)
Beschreibung

Non-ProtocolTherapyInd

Datentyp

text

Non-Protocol Therapy Type
Beschreibung

Non-ProtocolTherapyAdministeredType

Datentyp

text

Alias
NCI Thesaurus ValueDomain
C25284
UMLS 2011AA ValueDomain
C0332307
NCI Thesaurus ObjectClass
C15368
NCI Thesaurus ObjectClass
C25590
UMLS 2011AA ObjectClass
C1518384
NCI Thesaurus Property
C25382
UMLS 2011AA Property
C1521801
Radiation to other sites, specify
Beschreibung

Radiationtoothersites,specify

Datentyp

text

Other, specify
Beschreibung

Other,specify

Datentyp

text

Surgical procedure related to previous RT, specify
Beschreibung

SurgicalprocedurerelatedtopreviousRT,specify

Datentyp

text

Date of first non-protocol therapy
Beschreibung

Non-ProtocolTherapyDate,First

Datentyp

date

Specify (non-protocol prostate cancer therapy) (HAS A NEW PRIMARY CANCER OR MDS MYELODYSPLASTIC SYNDROME BEEN DIAGNOSED THAT HAS NOT BEEN PREVIOUSLY REPORTED?)
Beschreibung

Specify(non-protocolprostatecancertherapy)

Datentyp

text

New Primary Site
Beschreibung

NewPrimarySite

Datentyp

text

New Primary Site
Beschreibung

NewCancerDiagnosisAnatomicSite

Datentyp

text

Alias
NCI Thesaurus ValueDomain
C13717
UMLS 2011AA ValueDomain
C1515974
NCI Thesaurus ObjectClass
C25586
UMLS 2011AA ObjectClass
C0205314
NCI Thesaurus ObjectClass
C9305
UMLS 2011AA ObjectClass
C0006826
NCI Thesaurus Property
C15220
UMLS 2011AA Property
C0011900
New Primary Cancer Date
Beschreibung

NewPrimaryCancerDate

Datentyp

date

Alias
NCI Thesaurus ValueDomain
C25164
UMLS 2011AA ValueDomain
C0011008
Specify (new primary site)
Beschreibung

Specify(newprimarysite)

Datentyp

text

LATE RADIATION THERAPY ADVERSE EVENTS (REPORT ANY NEW OR CONTINUING EVENTS WHICH BEGAN >180 DAYS FROM THE START OF RT. If the toxicity is new, record the date it first appeared. Do not report tumor effects or those from non-protocol treatment or intercurrent disease. Code the most severe grade noted. USE THE RTOG/EORTC LATE RADIATION MORBIDITY SCORING SCHEMA Appendix IV. 8 = not evaluable, 9 = unknown, -1 = not applicable. If toxicity is grade 3 or greater, give detailed description of toxicity and provide any treatment given in the comments section.)
Beschreibung

LateAdverseEventInd

Datentyp

text

Late RT Adverse Event Grade
Beschreibung

LateAdverseEventGrade

Datentyp

text

Late RT Adverse Event Term
Beschreibung

LateAdverseEventTerm

Datentyp

text

BLADDER/OTHER GU Specify (late adverse event)
Beschreibung

BLADDER/OTHERGUSpecify(lateadverseevent)

Datentyp

text

SMALL/LARGE INTESTINE, specify (late adverse event)
Beschreibung

SMALL/LARGEINTESTINE,specify(lateadverseevent)

Datentyp

text

OTHER GI, specify (late adverse event)
Beschreibung

OTHERGI,specify(lateadverseevent)

Datentyp

text

OTHER, specify (late adverse event)
Beschreibung

OTHER,specify(lateadverseevent)

Datentyp

text

Late RT Adverse Event Onset Date
Beschreibung

LateAdverseEventOnsetDate

Datentyp

date

COMMENTS
Beschreibung

Comments

Datentyp

text

SIGNATURE
Beschreibung

SignatureofPersonCompletingThisForm

Datentyp

text

DATE
Beschreibung

FormCompletionDate,Original

Datentyp

date

Ccrr Module For F1 Radiation Therapy Oncology Group Phase Iii Randomized Study Of Intermediate Risk Prostate Cancer Follow-up Form Late Rt
Beschreibung

Ccrr Module For F1 Radiation Therapy Oncology Group Phase Iii Randomized Study Of Intermediate Risk Prostate Cancer Follow-up Form Late Rt

Zum Seitenanfang zurückkehren

Ähnliche Modelle

INSTRUCTIONS: Submit this form at the appropriate followup interval. Use -1 for unknown or not applicable unless otherwise specified in codetable. All dates to be reported mm-dd-yyyy unless otherwise indicated.

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Unnamed1
AmendedDataInd
Item
AMENDED DATA
text
C25474 (NCI Thesaurus ObjectClass)
C1511726 (UMLS 2011AA ObjectClass)
C25416 (NCI Thesaurus Property)
C1691222 (UMLS 2011AA Property)
Item Group
Unnamed2
RTOGStudy
Item
RTOG Study
text
Case#
Item
Case #
text
InstitutionName
Item
Institution Name
text
NCIInstitutionNumber
Item
Institution No.
text
PatientName,Last
Item
Patient Name, Last
text
PatientName,First
Item
Patient Name, First
text
Item Group
Unnamed3
Item Group
Unnamed4
Item
PATIENT'S VITAL STATUS
text
CL.1
Code List
PATIENT'S VITAL STATUS
CL Item
Alive (Alive)
CL Item
Dead (Dead)
DeathDate/LastContactDate
Item
DATE OF LAST CONTACT OR DEATH
date
Item
CAUSE OF DEATH
text
CL.2
Code List
CAUSE OF DEATH
CL Item
N/A (N/A)
CL Item
Due To This Disease (Due to this disease)
CL Item
Due To Protocol Treatment (Due to protocol treatment)
CL Item
Due To Other Cause (Due to other cause, specify)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
DeathCauseText
Item
Due to other cause, specify (cause of death)
text
C25638 (NCI Thesaurus Property)
C0392360 (UMLS 2011AA Property)
C28554 (NCI Thesaurus ObjectClass)
C0011065 (UMLS 2011AA ObjectClass)
C25251 (NCI Thesaurus Property)
C0205225 (UMLS 2011AA Property)
Item
HAS THE PATIENT HAD A DOCUMENTED CLINICAL ASSESSMENT FOR PROSTATE CANCER SINCE SUBMISSION OF THE PREVIOUS FOLLOWUP FORM?
text
CL.3
Code List
HAS THE PATIENT HAD A DOCUMENTED CLINICAL ASSESSMENT FOR PROSTATE CANCER SINCE SUBMISSION OF THE PREVIOUS FOLLOWUP FORM?
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
CancerFollow-upStatusDate
Item
DATE OF LAST CLINICAL ASSESSMENT
date
C2991 (NCI Thesaurus ObjectClass)
C0012634 (UMLS 2011AA ObjectClass)
C25365 (NCI Thesaurus Property)
C0678257 (UMLS 2011AA Property)
PerformanceStatus
Item
PERFORMANCE STATUS (ZUBROD)
text
PSAValue
Item
Follow-up PSA Value(s)
double
PSADate
Item
Date of PSA Assessment(s)
date
Item
HAS THE PATIENT HAD A PROSTATE BIOPSY SINCE SUBMISSION OF THE LAST FOLLOWUP FORM?
text
C25704 (NCI Thesaurus ValueDomain)
C1527021 (UMLS 2011AA ValueDomain)
C25180 (NCI Thesaurus ValueDomain)
C1522602 (UMLS 2011AA ValueDomain)
CL.4
Code List
HAS THE PATIENT HAD A PROSTATE BIOPSY SINCE SUBMISSION OF THE LAST FOLLOWUP FORM?
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
BiopsyDate
Item
Biopsy Date
date
Item
HAS THE PATIENT DEVELOPED A FIRST PROGRESSION THAT HAS NOT BEEN PREVIOUSLY REPORTED?
text
CL.5
Code List
HAS THE PATIENT DEVELOPED A FIRST PROGRESSION THAT HAS NOT BEEN PREVIOUSLY REPORTED?
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Item
HAS THE PATIENT BEEN DIAGNOSED WITH BIOCHEMICAL RECURRENCE SINCE SUBMISSION OF LAST FOLLOW-UP FORM? (See Protocol Section 11)
text
CL.6
Code List
HAS THE PATIENT BEEN DIAGNOSED WITH BIOCHEMICAL RECURRENCE SINCE SUBMISSION OF LAST FOLLOW-UP FORM? (See Protocol Section 11)
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
ProgressionDate,FirstBiochemical
Item
Date of first biochemical progression
date
ProgressionPSAValue
Item
PSA Value at progression
double
Item
HAS THE PATIENT BEEN DIAGNOSED WITH FIRST LOCAL-REGIONAL RECURRENCE SINCE SUBMISSION OF LAST FOLLOW-UP FORM? (See Protocol Section 11)
text
CL.7
Code List
HAS THE PATIENT BEEN DIAGNOSED WITH FIRST LOCAL-REGIONAL RECURRENCE SINCE SUBMISSION OF LAST FOLLOW-UP FORM? (See Protocol Section 11)
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
ProgressionDate,FirstLocal-Regional
Item
Date of First Local-Regional Progression
date
ProgressionSite
Item
Site(s) of Local/Regional Progression
text
Item
WHAT WAS THE METHOD USED TO DETERMINE distant PROGRESSION
text
CL.10
Code List
WHAT WAS THE METHOD USED TO DETERMINE distant PROGRESSION
CL Item
Clinical Examination (Physical exam)
CL Item
Pathologic (Pathologic)
CL Item
Radiographic (Radiographic)
CL Item
Nuclear scan (Nuclear scan)
CL Item
Other (Other, specify)
C17649 (NCI Thesaurus)
C0205394 (UMLS 2011AA)
Item
WHAT WAS THE METHOD USED TO DETERMINE distant PROGRESSION
text
CL.10
Code List
WHAT WAS THE METHOD USED TO DETERMINE distant PROGRESSION
CL Item
Clinical Examination (Physical exam)
CL Item
Pathologic (Pathologic)
CL Item
Radiographic (Radiographic)
CL Item
Nuclear scan (Nuclear scan)
CL Item
Other (Other, specify)
C17649 (NCI Thesaurus)
C0205394 (UMLS 2011AA)
AssessmentType,Specify
Item
Other, specify (method used to determine distant progression)
text
AssessmentType,Specify
Item
Other, specify (method used to determine distant progression)
text
Item
HAS THE PATIENT BEEN DIAGNOSED WITH FIRST DISTANT RECURRENCE SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM?
text
CL.9
Code List
HAS THE PATIENT BEEN DIAGNOSED WITH FIRST DISTANT RECURRENCE SINCE SUBMISSION OF THE LAST FOLLOW-UP FORM?
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
ProgressionDate,FirstDistant
Item
Date of First Distant Progression
date
ProgressionSite,FirstDistant
Item
Site(s) of First Distant Progression
text
Item Group
Unnamed5
AmendedDataInd
Item
AMENDED DATA
text
C25474 (NCI Thesaurus ObjectClass)
C1511726 (UMLS 2011AA ObjectClass)
C25416 (NCI Thesaurus Property)
C1691222 (UMLS 2011AA Property)
IntervalReportFromDate
Item
DATE FROM (Q2)
date
Item Group
Unnamed6
RTOGStudy
Item
RTOG Study
text
Case#
Item
Case #
text
InstitutionName
Item
Institution Name
text
NCIInstitutionNumber
Item
Institution No.
text
PatientName,Last
Item
Patient Name, Last
text
PatientName,First
Item
Patient Name, First
text
Item Group
Unnamed7
Item
DID THE PATIENT RECEIVE ANY NON-PROTOCOL PROSTATE CANCER THERAPY SINCE THE LAST FOLLOW-UP (If yes, enter therapy type and date for each therapy delivered during the follow-up period.)
text
CL.11
Code List
DID THE PATIENT RECEIVE ANY NON-PROTOCOL PROSTATE CANCER THERAPY SINCE THE LAST FOLLOW-UP (If yes, enter therapy type and date for each therapy delivered during the follow-up period.)
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
Item
Non-Protocol Therapy Type
text
C25284 (NCI Thesaurus ValueDomain)
C0332307 (UMLS 2011AA ValueDomain)
C15368 (NCI Thesaurus ObjectClass)
C25590 (NCI Thesaurus ObjectClass)
C1518384 (UMLS 2011AA ObjectClass)
C25382 (NCI Thesaurus Property)
C1521801 (UMLS 2011AA Property)
CL.12
Code List
Non-Protocol Therapy Type
CL Item
None (None)
C41132 (NCI Thesaurus)
C0549184 (UMLS 2011AA)
CL Item
Radiation To Pelvis (Radiation to pelvis)
CL Item
Radiation To Other Sites, Specify (Radiation to other sites, specify)
CL Item
Surgery (Surgery)
C17173 (NCI Thesaurus)
C0038894 (UMLS 2011AA)
CL Item
Chemotherapy (Chemotherapy)
C15632 (NCI Thesaurus)
C0392920 (UMLS 2011AA)
CL Item
Hormones (Hormones)
CL Item
Other Specify (Other, specify)
CL Item
Surgical Procedure Related To Previous Rt, Specify (Surgical procedure related to previous RT, specify)
Radiationtoothersites,specify
Item
Radiation to other sites, specify
text
Other,specify
Item
Other, specify
text
SurgicalprocedurerelatedtopreviousRT,specify
Item
Surgical procedure related to previous RT, specify
text
Non-ProtocolTherapyDate,First
Item
Date of first non-protocol therapy
date
Specify(non-protocolprostatecancertherapy)
Item
Specify (non-protocol prostate cancer therapy) (HAS A NEW PRIMARY CANCER OR MDS MYELODYSPLASTIC SYNDROME BEEN DIAGNOSED THAT HAS NOT BEEN PREVIOUSLY REPORTED?)
text
Item
New Primary Site
text
CL.13
Code List
New Primary Site
CL Item
None (None)
CL Item
AML/MDS (AML/MDS)
CL Item
BCC (BCC)
CL Item
Bladder (Bladder)
CL Item
Brain (Brain)
CL Item
Colorectal (Colorectal)
CL Item
Esophageal (Esophageal)
CL Item
Gastric (Gastric)
CL Item
Liver (Liver)
CL Item
Lung (Lung)
CL Item
Melanoma (Melanoma)
CL Item
NHL (NHL)
CL Item
Pancreatic (Pancreatic)
CL Item
Renal (Renal)
CL Item
Squamous-Skin (Squamous-Skin)
CL Item
Other Hematologic, specify (Other Hematologic, specify)
CL Item
Other solid, specify (Other solid, specify)
CL Item
Unknown primary (Unknown primary)
NewCancerDiagnosisAnatomicSite
Item
New Primary Site
text
C13717 (NCI Thesaurus ValueDomain)
C1515974 (UMLS 2011AA ValueDomain)
C25586 (NCI Thesaurus ObjectClass)
C0205314 (UMLS 2011AA ObjectClass)
C9305 (NCI Thesaurus ObjectClass)
C0006826 (UMLS 2011AA ObjectClass)
C15220 (NCI Thesaurus Property)
C0011900 (UMLS 2011AA Property)
NewPrimaryCancerDate
Item
New Primary Cancer Date
date
C25164 (NCI Thesaurus ValueDomain)
C0011008 (UMLS 2011AA ValueDomain)
Specify(newprimarysite)
Item
Specify (new primary site)
text
Item
LATE RADIATION THERAPY ADVERSE EVENTS (REPORT ANY NEW OR CONTINUING EVENTS WHICH BEGAN >180 DAYS FROM THE START OF RT. If the toxicity is new, record the date it first appeared. Do not report tumor effects or those from non-protocol treatment or intercurrent disease. Code the most severe grade noted. USE THE RTOG/EORTC LATE RADIATION MORBIDITY SCORING SCHEMA Appendix IV. 8 = not evaluable, 9 = unknown, -1 = not applicable. If toxicity is grade 3 or greater, give detailed description of toxicity and provide any treatment given in the comments section.)
text
CL.14
Code List
LATE RADIATION THERAPY ADVERSE EVENTS (REPORT ANY NEW OR CONTINUING EVENTS WHICH BEGAN >180 DAYS FROM THE START OF RT. If the toxicity is new, record the date it first appeared. Do not report tumor effects or those from non-protocol treatment or intercurrent disease. Code the most severe grade noted. USE THE RTOG/EORTC LATE RADIATION MORBIDITY SCORING SCHEMA Appendix IV. 8 = not evaluable, 9 = unknown, -1 = not applicable. If toxicity is grade 3 or greater, give detailed description of toxicity and provide any treatment given in the comments section.)
CL Item
No (No)
C49487 (NCI Thesaurus)
C1298908 (UMLS 2011AA)
CL Item
Yes (Yes)
C49488 (NCI Thesaurus)
C1705108 (UMLS 2011AA)
CL Item
Unknown (Unknown)
C17998 (NCI Thesaurus)
C0439673 (UMLS 2011AA)
LateAdverseEventGrade
Item
Late RT Adverse Event Grade
text
Item
Late RT Adverse Event Term
text
CL.15
Code List
Late RT Adverse Event Term
CL Item
SKIN (SKIN)
CL Item
BLADDER/OTHER GU Specify (BLADDER/OTHER GU Specify)
CL Item
SMALL/LARGE INTESTINE, specify (SMALL/LARGE INTESTINE, specify)
CL Item
OTHER GI, specify (OTHER GI, specify)
CL Item
OTHER, specify (OTHER, specify)
BLADDER/OTHERGUSpecify(lateadverseevent)
Item
BLADDER/OTHER GU Specify (late adverse event)
text
SMALL/LARGEINTESTINE,specify(lateadverseevent)
Item
SMALL/LARGE INTESTINE, specify (late adverse event)
text
OTHERGI,specify(lateadverseevent)
Item
OTHER GI, specify (late adverse event)
text
OTHER,specify(lateadverseevent)
Item
OTHER, specify (late adverse event)
text
LateAdverseEventOnsetDate
Item
Late RT Adverse Event Onset Date
date
Comments
Item
COMMENTS
text
SignatureofPersonCompletingThisForm
Item
SIGNATURE
text
FormCompletionDate,Original
Item
DATE
date
Item Group
Ccrr Module For F1 Radiation Therapy Oncology Group Phase Iii Randomized Study Of Intermediate Risk Prostate Cancer Follow-up Form Late Rt
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video